Healthcare -
Biotechnology - NASDAQ - US
$ 1.36
2.26 %
$ 32.6 M
Market Cap
-2.34
P/E
RNXT - OPERATING INCOME
Operating Income RNXT - RenovoRx, Inc.
-11.4 M
LAST VALUE
-41.76%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR